Chronic Inflammation E66 E11
Conditions
Interventions
Group 1: placebo
Group 2: functional food product (oligosaccharides and oligopeptides of milk), application in a once daily version over a time period of 4 weeks).
Sponsors
UKSH Universitätsklinikum Schleswig-Holstein
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: n=1500 cross sectional controls (govermental registration office), n=500 obesity (BMI > 30 kg/m2)
Exclusion criteria
Exclusion criteria: non
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin-6, wnt5a and sFRP5 will be measured as biomarkers for inflammation at beginning, week 1, week 2, week 3 and at the end of the study by ELISA using probands serum samples. | — |
Countries
Germany
Contacts
Public ContactMatthias Laudes
UKSH, Campus Kiel Klinik für Innere Medizin 1
Outcome results
None listed